Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1971)
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
3,161
Price
$215.38
Total Value
$680.82K
Shares Held After
2,343,039
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
5,707
Price
$214.35
Total Value
$1.22M
Shares Held After
2,346,200
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
5,034
Price
$213.43
Total Value
$1.07M
Shares Held After
2,351,907
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
12,142
Price
$212.27
Total Value
$2.58M
Shares Held After
2,356,941
% of Holdings
0.5%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,957
Price
$211.61
Total Value
$625.74K
Shares Held After
2,369,083
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
3,267
Price
$210.30
Total Value
$687.05K
Shares Held After
2,372,040
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,536
Price
$209.50
Total Value
$531.28K
Shares Held After
2,375,307
% of Holdings
0.1%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
6,250
Price
$35.08
Total Value
$219.22K
Shares Held After
793
% of Holdings
88.7%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
11,322
Price
$0.40
Total Value
$4.53K
Shares Held After
349,907
% of Holdings
3.1%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
159,119
Price
$0.40
Total Value
$63.65K
Shares Held After
4,917,566
% of Holdings
3.1%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
391,019
Price
$8.57
Total Value
$3.35M
Shares Held After
16,622,736
% of Holdings
2.4%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
19,842
Price
$74.05
Total Value
$1.47M
Shares Held After
22,458
% of Holdings
46.9%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
41,004
Price
$73.09
Total Value
$3.00M
Shares Held After
42,300
% of Holdings
49.2%
Cigna Group (CI)
Kates Jamie G — Chief Accounting Officer
Shares
899
Price
$298.61
Total Value
$268.45K
Shares Held After
2,368
% of Holdings
27.5%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
15,856
Price
$18.68
Total Value
$296.19K
Shares Held After
273,320
% of Holdings
5.5%
Travere Therapeutics, Inc. (TVTX)
Coughlin Timothy — Director
Shares
10,000
Price
$50.07
Total Value
$500.75K
Shares Held After
56,250
% of Holdings
15.1%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
4,500
Price
$50.00
Total Value
$225.00K
Shares Held After
41,500
% of Holdings
9.8%
Omada Health, Inc. (OMDA)
Shao Wei-Li — President
Shares
4,589
Price
$17.24
Total Value
$79.12K
Shares Held After
316,238
% of Holdings
1.4%
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
6,894
Price
$17.42
Total Value
$120.12K
Shares Held After
9,191
% of Holdings
42.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
13,095
Price
$72.15
Total Value
$944.86K
Shares Held After
1,065,135
% of Holdings
1.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
97,954
Price
$71.37
Total Value
$6.99M
Shares Held After
1,078,230
% of Holdings
8.3%
Ridgetech Inc. (RDGT)
HRT FINANCIAL LP — 10% Owner
Shares
6,526
Price
$1.51
Total Value
$9.85K
Shares Held After
127,842
% of Holdings
4.9%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
4,252,767
Price
$0.02
Total Value
$68.04K
Shares Held After
2,459,308
% of Holdings
172.9%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
2,102
Price
$3.36
Total Value
$7.06K
Shares Held After
106,675
% of Holdings
1.9%
WORK Medical Technology Group LTD (WOK)
HRT FINANCIAL LP — 10% Owner
Shares
48,108
Price
$0.08
Total Value
$3.85K
Shares Held After
3,027,096
% of Holdings
1.6%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
21,000
Price
$2.50
Total Value
$52.50K
Shares Held After
630,812
% of Holdings
3.3%
111, Inc. (YI)
Chen Yang Luke — Director
Shares
49,920
Price
$0.23
Total Value
$11.48K
Shares Held After
539,462
% of Holdings
8.5%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
12,996
Price
$3.94
Total Value
$51.20K
Shares Held After
136,381
% of Holdings
8.7%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
3,461
Price
$256.08
Total Value
$886.29K
Shares Held After
4,981
% of Holdings
41.0%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
3,000
Price
$255.01
Total Value
$765.03K
Shares Held After
8,442
% of Holdings
26.2%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Senderowicz Adrian — Director
Shares
27,000
Price
$7.20
Total Value
$194.31K
Shares Held After
27,000
% of Holdings
50.0%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Stuglik Brian M — Director
Shares
8,100
Price
$7.20
Total Value
$58.31K
Shares Held After
113,858
% of Holdings
6.6%
PUMA BIOTECHNOLOGY, INC. (PBYI)
MOYES JAY M — Director
Shares
22,000
Price
$7.22
Total Value
$158.80K
Shares Held After
58,322
% of Holdings
27.4%
PUMA BIOTECHNOLOGY, INC. (PBYI)
WILSON TROY EDWARD — Director
Shares
10,800
Price
$7.20
Total Value
$77.75K
Shares Held After
59,750
% of Holdings
15.3%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
1,654
Price
$2.23
Total Value
$3.69K
Shares Held After
505,094
% of Holdings
0.3%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
2,584
Price
$2.23
Total Value
$5.77K
Shares Held After
512,319
% of Holdings
0.5%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Dorval Allison — Director
Shares
11,610
Price
$7.20
Total Value
$83.58K
Shares Held After
90,780
% of Holdings
11.3%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$82.03
Total Value
$41.02K
Shares Held After
77,890
% of Holdings
0.6%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
3,260
Price
$70.34
Total Value
$229.31K
Shares Held After
17,294
% of Holdings
15.9%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,340
Price
$69.85
Total Value
$303.15K
Shares Held After
20,554
% of Holdings
17.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
1,859
Price
$68.34
Total Value
$127.05K
Shares Held After
24,894
% of Holdings
6.9%
Cytosorbents Corp (CTSO)
Chan Phillip P. — Director
Shares
251,136
Price
$0.40
Total Value
$100.45K
Shares Held After
1,734,099
% of Holdings
14.5%
Alignment Healthcare, Inc. (ALHC)
Kim Hyong — Chief Medical Officer
Shares
35,951
Price
$19.86
Total Value
$713.95K
Shares Held After
331,750
% of Holdings
9.8%
FRACTYL HEALTH, INC. (GUTS)
Royan Ajay — Director
Shares
23,000
Price
$0.85
Total Value
$19.60K
Shares Held After
40,901
% of Holdings
56.2%
Elevance Health, Inc. (ELV)
Penczek Ronald W — CAO & Controller
Shares
369
Price
$403.16
Total Value
$148.77K
Shares Held After
3,740
% of Holdings
9.0%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
5,000
Price
$4.95
Total Value
$24.75K
Shares Held After
245,780
% of Holdings
2.0%
DENTSPLY SIRONA Inc. (XRAY)
MCKEON BRIAN P — Director
Shares
10,000
Price
$10.12
Total Value
$101.20K
Shares Held After
10,000
% of Holdings
100.0%
60 DEGREES PHARMACEUTICALS, INC. (SXTP)
DOW GEOFFREY S — Director
Shares
7,350
Price
$1.38
Total Value
$10.13K
Shares Held After
24,131
% of Holdings
30.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
743
Price
$545.71
Total Value
$405.46K
Shares Held After
40,513
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$544.45
Total Value
$304.89K
Shares Held After
41,256
% of Holdings
1.3%
Showing 251–300 of 1971 transactions (page 6 of 40)